title: Modeling Contrast-Imaging-Assisted Optimal Targeted Drug Delivery: A Touchable Communication Channel Estimation and Waveform Design Perspective.
abstract: To maximize the effect of treatment and minimize the adverse effect on patients, we propose to optimize nanorobots-assisted targeted drug delivery (TDD) for locoregional treatment of tumor from the perspective of touchable communication channel estimation and waveform design. The drug particles are the information molecules; the loading/injection and unloading of the drug correspond to the transmitting and receiving processes; the concentration-time profile of the drug particles administered corresponds to the signaling pulse. Given this analogy, we first propose to use contrast-enhanced microwave imaging (CMI) as a pretherapeutic evaluation technique to determine the pharmacokinetic model of nanorobots-assisted TDD. The CMI system applies an information-theoretic-criteria-based algorithm to estimate drug accumulation in tumor, which is analogous to the estimation of channel impulse response in the communication context. Subsequently, we present three strategies for optimal targeted therapies from the communication waveform design perspective, which are based on minimization of residual drug molecules at the end of each therapeutic session (i.e., inter-symbol interference), maximization of duration when the drug intensity is above a prespecified threshold during each therapeutic session (i.e., non-fade duration), and minimization of average rate that a therapeutic operation is not received correctly at tumor (i.e., bit error rate). Finally, numerical examples are applied to demonstrate the effectiveness of the proposed analytical framework.
authors.forename: Yifan
authors.initials: Y
authors.lastname: Chen
authors.forename: Yu
authors.initials: Y
authors.lastname: Zhou
authors.forename: Ross
authors.initials: R
authors.lastname: Murch
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Kosmas
mesh_terms: D003287:Contrast Media / Q000627:therapeutic use*; D003952:Diagnostic Imaging; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008872:Microwaves / Q000627:therapeutic use*; D008962:Models, Theoretical; D050997:Nanomedicine / Q000379:methods*; D012371:Robotics; D012815:Signal Processing, Computer-Assisted
chemical_list: D003287:Contrast Media